Medicine composition for treating gastrointestinal motility disorder

Abstract

The invention relates to a medicine composition for treating gastrointestinal motility disorder. The composition is characterized by comprising the following raw medicines in parts by weight: 10-20 parts of zedoary, 7-15 parts of fructus amomi, 7-15 parts of betel nut, 7-15 parts of costus root and 7-15 parts of spikenard. According to the technical scheme, zedoary, fructus amomi, betel nut, costus root and spikenard are composited on the basis of theory of traditional Chinese medicine and through the adjustment of the lifting motion of spleen and stomach and the synergistic effect on the aspects of promoting qi circulation, resolving dampness, eliminating accumulation, stopping pain and the like, the purposes of promoting gastrointestinal motility and treating gastrointestinal motility disorder are achieved.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating gastrointestinal motility disorder. Background technique [0002] Gastrointestinal motility is an important part of the physiological function of the digestive tract, and its dysfunction is one of the decisive factors causing gastrointestinal symptoms. Abnormal gastrointestinal motility is closely related to a variety of digestive system diseases and gastrointestinal complications of other system diseases. Diseases caused by gastrointestinal motility disorders are common diseases in clinical gastroenterology. For example, functional dyspepsia with gastrointestinal motility disorders as the main symptom accounts for more than 1 / 3 of outpatients in gastrointestinal specialist clinics, which has a significant impact on the lives of patients. If the impact of abnormal dynamics caused by organic lesions such as gastritis and ulcers...

AI Technical Summary

Problems solved by technology

However, there is still a lack of very effective treatment methods in clinical practice, and the understanding and research of it in modern medicine only started in the last 20 years, and there are still many basic and clinical issues that have not been elucidated.

In recent years, with the in-depth research on gastrointestinal motility, gastrointestinal motility drugs such as domperidone and cisapride have been widely used clinically, but the curative effect of western medicine is not good at present, and the symptoms are repeated, which seriously affects the work and life of patients.